ARTICLE | Company News
Aros Applied Biotechnology, Stratagene deal
September 18, 2006 7:00 AM UTC
Aros granted STGN an exclusive option to evaluate and license patents and patent applications covering a family of gene expression predictors for bladder cancer. Financial terms were not disclosed. ...